| Order book | ₹71,846 Cr |
|---|
BSE filing, NSE: KPIL. Summary written from the filing by ALFA Finder's alert engine.
Kalpataru Projects International Ltd: key numbers
- Share price
- ₹1,374.00
- Market cap
- ₹23,464 Cr
- Revenue (annual)
- ₹27,143 Cr
- Net profit (annual)
- ₹1,040 Cr
- P/E (TTM)
- 20.6×Sector 32.7×
- Promoter holding
- 33.58%+0.00% QoQ
- FII holding
- 10.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalpataru Projects International Ltd
All →Kalpataru Projects International Investor Presentation: Key Takeaways
Q2 FY27 consolidated ex-SPV revenue ₹6,995 cr (+13%); H1 ₹13,391 cr (+11%). H1 PAT ₹603 cr (+34%), near debt-free, order book ₹71,846 cr.
Kalpataru Projects International Q2 FY27 Results: Net Profit ₹291.9 Cr, Up 23.0% YoY
Kalpataru Projects International Ltd reported revenue from operations of ₹7,004 Cr (+7.3% YoY) and net profit of ₹291.9 Cr (+23.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹291.9 Cr · +23.0% YoY
Kalpataru Projects International Promoter Reclassification
Kalpataru Projects received Regulation 31A requests from Imtiaz and Yasmin Kanga to reclassify from Promoter Group to Public. Board consideration and exchange approvals are pending.
Kalpataru Projects International Board Meeting Date
Kalpataru Projects will hold a board meeting on November 5, 2026 to approve quarterly and half-year results. An investor call follows on November 6, and the trading window stays closed.
Kalpataru Projects International Legal & Regulatory
KPIL received a GST order demanding INR 6.76 Crore penalty for FY 2018-19 and 2020-21. The company plans to appeal before the first Appellate Authority.
- Value
- ₹6.76 Cr
Kalpataru Projects International IPO
Kalpataru's subsidiary Linjemontage's IPO over-allotment option was exercised for 18.8 lakh shares, ending stabilisation. Unexercised shares return to Kalpataru Sweden, leaving its stake at 66.45%.
Other results update announcements
All →Paras Healthcare Results Update
Paras Healthcare reported Q2 FY27 revenue of Rs. 510.9 crore, up 22.8% YoY, through a press release. These are its first results since its October 2026 listing.
AstraZeneca Pharma India Results Update
AstraZeneca Pharma India reported 30% growth in Q2 results, with three new regulatory approvals. It also announced MoUs with two state governments.
BCPL Railway Infrastructure Results Update
BCPL Railway's H1 FY27 standalone revenue fell 7.80% to Rs 4,982.46 lacs, while consolidated revenue rose 26.44% to Rs 16,209.53 lacs. Consolidated PAT was Rs 527.66 lacs.
Meta Infotech Results Update
Meta Infotech's H1FY27 revenue fell 57% YoY to Rs 895 Million, while PAT was Rs 49 Million. Gross margin improved to 32.2% as it shifted toward services.
B.R.Goyal Infrastructure Results Update
B.R.Goyal Infrastructure released H1 FY27 unaudited results, with revenue up 60.67% and PAT up 37.82%. Order book stood at Rs 1,755 Crore on September 30, 2026.
Sula Vineyards Results Update
Sula Vineyards reported Q2 FY27 net profit up 34% YoY to Rs 8.1 Crore. The release also flags a fourth hotel and upcoming product launches.